benztropine <mesylate> (Cogentin)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Cogentin.

Indications

Dosage

1-2 mg IM/PO QD/BID

Tabs: 0.5, 1, 2 mg.

Injection: 1 mg/mL, 2 mL vials.

Adverse effects

Drug interactions

Laboratory

Mechanism of action

More general terms

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996.
  2. The Pharmacological Basis of Therapeutics, 8th ed. Gilman et al, eds. Permagon Press/McGraw Hill pg 477
  3. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 1052
  4. Kaiser Permanente Northern California Regional Drug Formulary, 1998.
  5. 5.0 5.1 Rosenheck R et al, JAMA 290:2693, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14645311
  6. 6.0 6.1 Deprecated Reference
  7. Department of Veterans Affairs, VA National Formulary

Database